We appreciate the opportunity to comment on ASCO’s Conceptual Framework to Assess the Value of Cancer Treatment Options. At Friends of Cancer Research, our mission is to ensure that patients have access to the best treatment options available to them. Fortunately, advances in basic and medical applied sciences have led to the development of several…
Washington, DC (10 July, 2015) – Friends of Cancer Research (Friends) congratulates Representatives Fred Upton (R-MI) and Diana DeGette (D-CO), along with their colleagues, on the successful House vote on the 21st Century Cures Act.This victory follows months of legislative and advocacy work and represents a truly bipartisan success on behalf of patients. The bill,…
Today the 21st Century Cures Act was unanimously voted out of committee. Act creates a cohesive, efficient, effective & patient-centered path to cures. The 21st Century Cures Act, a substantial piece of legislation that touches on all aspects of medical innovation – from basic research to regulation, from biomarkers to patient data – was spearheaded…
For Immediate Release Contact: Ryan Hohman, JD, Managing Director, Policy & Public Affairs at rhohman@focr.org or 202.944.6708 Washington, DC (May 1, 2015) – Friends of Cancer Research (Friends) congratulates Chairman Fred Upton (R-MI), Rep. Diana DeGette (D-CO), along with their colleagues, for advancing the 21st Century Cures initiative with the release of draft legislation that puts…
Ahead of FDA’s Workshop on NGS, Friends of Cancer Research is Releasing the Final Whitepaper from our September 2014 Meeting WASHINGTON, DC (February 18, 2015) – Today, Friends of Cancer Research (Friends) released a whitepaper titled: “A Blueprint for Drug/Diagnostic Co-Development; Next Generation Sequencing (NGS) in Oncology.” The original draft of this whitepaper was released at the 3rd…
As Dr. Hamburg steps down as Commissioner, we are deeply indebted to her for all she has done for science and for patients Washington, DC, February 5, 2015 – Friends of Cancer Research would like to applaud Dr. Margaret Hamburg for her incredible, transformative leadership during her time as FDA Commissioner. “Commissioner Hamburg’s leadership and her commitment…
The Bonnie J. Addario Lung Cancer Foundation (ALCF), in collaboration with Foundation Medicine and Friends of Cancer Research, and in partnership with many advocacy organizations, today launched the “Don’t Guess. Test.” campaign to expand awareness and educate patients about precision medicine and the importance of comprehensive genomic testing in lung cancer. Through extensive grassroots and…
A Blueprint For Drug/Diagnostic Co-development Washington, DC, September 30, 2014 – Today, Friends of Cancer Research (Friends) and Alexandria Real Estate Equities, Inc/Alexandria Venture Investments (NYSE:ARE) will host the 3rd Annual Blueprint for Drug/Diagnostic Co-development forum. This annual conference brings together researchers, sponsors, advocates, policy-makers and regulators to develop consensus-driven solutions to address…
Collaboration to feature policy briefings on “Cancer Research in the 21st Century”; speakers for inaugural event include Dr. Francis Collins, Dr. Ronald DePinho, and moderator Susan Page of USA Today Washington, DC, September 18, 2014 –– The Aspen Institute Health, Medicine, and Society Program and Friends of Cancer Research (Friends) announce a new partnership, which…
Groundbreaking study in squamous cell lung cancer opens at more than a hundred and fifty new locations The Lung-MAP trial, a multi-drug, multi-sub-study, biomarker-driven clinical trial for patients with advanced squamous cell lung cancer, that launched on June 16th 2014, today announced that it has expanded to an additional 169 locations throughout the United States.…
